These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29077903)

  • 1. Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
    Raue F; Dralle H; Machens A; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2018 Jan; 103(1):235-243. PubMed ID: 29077903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
    Wray CJ; Rich TA; Waguespack SG; Lee JE; Perrier ND; Evans DB
    Ann Surg Oncol; 2008 Jan; 15(1):293-301. PubMed ID: 17963006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
    Brauckhoff M; Machens A; Lorenz K; Bjøro T; Varhaug JE; Dralle H
    Ann Surg; 2014 Apr; 259(4):800-6. PubMed ID: 23979292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
    Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
    Castinetti F; Waguespack SG; Machens A; Uchino S; Hasse-Lazar K; Sanso G; Else T; Dvorakova S; Qi XP; Elisei R; Maia AL; Glod J; Lourenço DM; Valdes N; Mathiesen J; Wohllk N; Bandgar TR; Drui D; Korbonits M; Druce MR; Brain C; Kurzawinski T; Patocs A; Bugalho MJ; Lacroix A; Caron P; Fainstein-Day P; Borson Chazot F; Klein M; Links TP; Letizia C; Fugazzola L; Chabre O; Canu L; Cohen R; Tabarin A; Spehar Uroic A; Maiter D; Laboureau S; Mian C; Peczkowska M; Sebag F; Brue T; Mirebeau-Prunier D; Leclerc L; Bausch B; Berdelou A; Sukurai A; Vlcek P; Krajewska J; Barontini M; Vaz Ferreira Vargas C; Valerio L; Ceolin L; Akshintala S; Hoff A; Godballe C; Jarzab B; Jimenez C; Eng C; Imai T; Schlumberger M; Grubbs E; Dralle H; Neumann HP; Baudin E
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):213-220. PubMed ID: 30660595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
    Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
    Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
    Lodish MB; Stratakis CA
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
    Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
    Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
    Jasim S; Ying AK; Waguespack SG; Rich TA; Grubbs EG; Jimenez C; Hu MI; Cote G; Habra MA
    Thyroid; 2011 Feb; 21(2):189-92. PubMed ID: 21186952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the genotype-phenotype correlation in children with medullary thyroid carcinoma: A report from the GPOH-MET registry.
    Kuhlen M; Frühwald MC; Dunstheimer DPA; Vorwerk P; Redlich A
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28171. PubMed ID: 31925938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
    Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
    Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
    Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
    J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
    Mathiesen JS; Døssing H; Bender L; Godballe C
    Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.